Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Annals of the Academy of Medicine, Singapore|November 11, 2010
Staging of benign prostate hyperplasia is helpful in patients with lower urinary tract symptoms suggestive of benign prostate hyperplasiaDelin Wang, Keong Tatt FooBMC Cancer|January 29, 2026
C21orf2 as a potential regulator of JAK2/STAT3 signaling in prostate cancer cell proliferation and apoptosis: an exploratory studyShiHao Jiang, Shuai Su, Delin WangMedicine|June 1, 2018
The relationship between body mass index changes during chemotherapy and prognosis of patients with advanced colorectal cancer: A retrospective cohort studyZhao Cong, Delin Wang, Yujuan CaoFrontiers in Oncology|July 7, 2022
Case Report: Surgical Intervention Under Pheochromocytoma Multisystem Crisis: Timing and ApproachShengjun Luo, Qingao Cui, Delin WangCell Biology International|June 20, 2023
Renal clear cancer cells regulate the differentiation of urine-derived stem cells to carcinoma-associated fibroblasts via RUNX3/TGF-β1 signaling axisLiang Chen, Shengjun Luo, Xiangna Gao, et al.Archivos Espanoles De Urologia|September 6, 2024
FBXO45 Knockdown Restrains the Progression of Bladder Cancer via the ERK/Cyclin D1/CDK4 PathwayWeiyang Zhang, Qingyuan Liu, Jindong Zhang, et al.Molecular Carcinogenesis|November 2, 2025
NSUN2 Promotes Prostate Cancer Cell Proliferation and Migration Through m5C Modifications of YES1Tianming Chen, Xiaokang Yang, Shuai Su, et al.Frontiers in Immunology|October 17, 2022
Prognostic value of programmed cell death ligand-1 expression in patients with bladder urothelial carcinoma undergoing radical cystectomy: A meta-analysisJindong Zhang, Liangdong Song, Huixuan Zhu, et al.Pakistan Journal of Pharmaceutical Sciences|December 1, 2022
Efficacy of Shuganjieyu capsule for treatment of neurologic disorders combined with depression: A meta-analysisXiao Huang, Tian Song, Zhou Ding, et al.Discover Oncology|February 10, 2025
DPH2 is a biomarker associated with cell death, immunity and prognosis based on pan-cancer analysisMaolin Xiao, Shuai Su, Xiangbiao He, et al.Pageof 8